Quel est le prix pour Valeo Pharma Inc. (VPHIF)

Le prix pour Valeo Pharma Inc. (VPHIF) est $0.0001

Quelle est la capitalisation boursière pour Valeo Pharma Inc. (VPHIF)

La capitalisation boursière pour Valeo Pharma Inc. (VPHIF) est $9.87K

Valeo Pharma Inc. (VPHIF) Prix et Capitalisation Boursière

Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to sourcing, licensing, and selling a variety of medicinal products, with a primary emphasis on respiratory, specialized, and hospital-grade generic drugs. Its extensive product lineup features prominent asthma medications like Enerzair Breezhaler (a triple-combination LABA/LAMA/ICS) and Atectura Breezhaler (a dual-combination LABA/ICS). The company also offers Redesca, crucial for preventing and treating deep vein thrombosis and pulmonary embolism. For neurological conditions, Valeo markets Onstryv, an add-on treatment for Idiopathic Parkinson's Disease in patients on stable Levodopa, and Benztropine, an anticholinergic for PD. Pain management is addressed with M-Eslon, an extended-release morphine sulfate, while Yondelis targets soft tissue sarcoma. Beyond these, the portfolio includes Hesperco, an immune-supporting bioflavonoid antioxidant; Ametop, a skin anesthetic used before venous procedures; Ethacrynate Sodium, a loop diuretic for high blood pressure and swelling; and Amikacin, an injectable antibiotic. Founded in 2003, Valeo Pharma Inc. is headquartered in Kirkland, Canada.

Prix pour VPHIF	L’actif B	La capitalisation boursière de B	Résultats
$54,564.76 $9.87K	NVDA	$5.383T	+54,564,762,316.38%
$44,834.70 $9.87K	AAPL	$4.423T	+44,834,696,876.87%
$42,168.76 $9.87K	GOOG	$4.160T	+42,168,755,212.00%
$37,130.76 $9.87K	MSFT	$3.663T	+37,130,760,461.52%
$29,304.97 $9.87K	AMZN	$2.891T	+29,304,974,513.83%

Prix pour VPHIF

L’actif B

La capitalisation boursière de B

Résultats

$54,564.76 $9.87K